Idiopathic maculopathy in eyes with regressed retinopathy of prematurity

Kyoung Min Lee1, Jeong Hun Kim, Young Suk Yu

  • 1Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, 110-744, Republic of Korea.

Insights

Idiopathic maculopathy in former preterm infants with regressed retinopathy of prematurity presents as geographic atrophy. This rare condition, distinct from cicatricial changes, shows no progression over time.

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Pediatric Ophthalmology

Background:

  • Idiopathic maculopathy is a rare posterior pole condition observed in eyes with regressed retinopathy of prematurity.
  • It is crucial to differentiate this entity from cicatricial changes associated with retinopathy of prematurity.

Purpose of the Study:

  • To describe the clinical characteristics of idiopathic maculopathy in eyes with regressed retinopathy of prematurity.
  • To distinguish idiopathic maculopathy from cicatricial changes in retinopathy of prematurity.

Main Methods:

  • Retrospective review of medical records and fundus photographs of eight eyes (four patients) with idiopathic maculopathy.
  • Exclusion of posterior polar cicatricial changes.
  • Ophthalmologic examinations included visual acuity, refractive error, funduscopy, fluorescein angiography (FAG), and optical coherence tomography (OCT).

Main Results:

  • Maculopathy presented as depigmented geographic atrophy with FAG showing RPE window defects.
  • OCT revealed foveal depression with preserved internal retinal architecture.
  • All patients had retinopathy of prematurity, with maculopathy detected after laser photocoagulation in most cases; it was bilateral and associated with myopia.
  • Visual acuity varied, and no progression was observed over an 8-year follow-up.

Conclusions:

  • Idiopathic maculopathy is a distinct posterior polar change in regressed retinopathy of prematurity, separate from cicatricial changes.
  • The condition appears independent of prior laser photocoagulation treatment.
  • No progression was noted, suggesting a fair visual prognosis.
Abstract